Influence of Co-Vid 19 Pandemic on Screening Mammography Single Institution
- Conditions
- COVID-19Breast Cancer
- Interventions
- Other: surgery
- Registration Number
- NCT04750018
- Lead Sponsor
- Chen-Pin Chou
- Brief Summary
To assess whether the COVID-19 pandemic delayed breast cancer diagnosis in Taiwan, an Asian country with a low COVID-19 incidence.
- Detailed Description
The institutional review board approved this retrospective study at a public academic medical center. The monthly volume of breast biopsies and breast cancers during the COVID-19 pandemic (between January 1 and July 31, 2020) was compared to the same period a year earlier (pre-COVID-19).
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- Female
- Target Recruitment
- 600
Inclusion Criteria
- Receiving breast exam 2019-2020
Exclusion Criteria
- lost clinical follow-up
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description COVID-19 2020 surgery Patients receiving biopsies with a BI-RADS assessment of 4 or 5 from mammographic or ultrasonographic exams or combinations of tests were analyzed \[4\]. We further categorized the biopsy data as ultrasound-guided or mammograph-guided biopsy based on procedure coding. Ultrasound-guided core needle biopsy (CNB) was performed for breast lesions visible on ultrasound.
- Primary Outcome Measures
Name Time Method breast cancer 1 year Breast cancer or not
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Radiology depart
🇨🇳Kaohsiung, Taiwan